Noxopharm Limited (ASX:NOX)
Australia
· Delayed Price · Currency is AUD 0.0700
-0.0010 (-1.41%)
May 14, 2025, 3:25 PM AEST
Noxopharm Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
| Cash & Equivalents | 1.04 | 2.32 | 3.01 | 14.01 | 26.8 | 7.1 | Upgrade
|
| Cash & Short-Term Investments | 4.18 | 2.32 | 3.01 | 14.01 | 26.8 | 7.1 | Upgrade
|
| Cash Growth | -19.01% | -22.89% | -78.53% | -47.71% | 277.40% | 144.03% | Upgrade
|
| Accounts Receivable | - | - | - | 0.01 | 0 | 0.01 | Upgrade
|
| Other Receivables | 1.22 | 2.4 | 6.08 | 5.21 | 5.79 | 4.64 | Upgrade
|
| Receivables | 1.22 | 2.4 | 6.08 | 5.21 | 5.8 | 4.65 | Upgrade
|
| Inventory | - | - | - | 1.15 | 0.31 | 0.52 | Upgrade
|
| Prepaid Expenses | 0.06 | 0.04 | 0.07 | 0.46 | 0.07 | 0.06 | Upgrade
|
| Total Current Assets | 5.46 | 4.77 | 9.16 | 20.83 | 32.97 | 12.33 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.01 | 0.01 | 0.22 | 0.48 | 0.85 | Upgrade
|
| Long-Term Investments | - | 2.01 | 0.96 | 5.42 | 14.27 | 6.54 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.12 | 0.12 | 0.12 | Upgrade
|
| Total Assets | 5.47 | 6.78 | 10.13 | 26.59 | 47.85 | 20.07 | Upgrade
|
| Accounts Payable | 0.63 | 0.65 | 0.45 | 0.81 | 0.96 | 1.79 | Upgrade
|
| Accrued Expenses | 0.32 | 0.51 | 0.41 | 1.14 | 5.53 | 0.31 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 4.34 | Upgrade
|
| Current Portion of Leases | - | - | - | 0.16 | 0.23 | 0.24 | Upgrade
|
| Other Current Liabilities | 0.16 | 0.08 | 0.1 | 0.17 | 0.08 | - | Upgrade
|
| Total Current Liabilities | 1.11 | 1.25 | 0.96 | 2.28 | 6.81 | 6.69 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.12 | 0.41 | Upgrade
|
| Total Liabilities | 1.14 | 1.29 | 1.06 | 2.48 | 7.08 | 7.19 | Upgrade
|
| Common Stock | 74.64 | 74.64 | 74.64 | 74.64 | 72.62 | 41.63 | Upgrade
|
| Retained Earnings | -71 | -70.07 | -72.06 | -58.8 | -40.33 | -31.47 | Upgrade
|
| Comprehensive Income & Other | 0.69 | 0.93 | 6.5 | 8.29 | 8.49 | 2.71 | Upgrade
|
| Total Common Equity | 4.32 | 5.5 | 9.07 | 24.12 | 40.78 | 12.87 | Upgrade
|
| Shareholders' Equity | 4.32 | 5.5 | 9.07 | 24.12 | 40.78 | 12.87 | Upgrade
|
| Total Liabilities & Equity | 5.47 | 6.78 | 10.13 | 26.59 | 47.85 | 20.07 | Upgrade
|
| Total Debt | - | - | - | 0.16 | 0.35 | 5 | Upgrade
|
| Net Cash (Debt) | 4.18 | 2.32 | 3.01 | 13.85 | 26.45 | 2.1 | Upgrade
|
| Net Cash Growth | -19.01% | -22.89% | -78.28% | -47.63% | 1159.30% | - | Upgrade
|
| Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.05 | 0.10 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 292.24 | 292.24 | 292.24 | 292.24 | 288.23 | 213.24 | Upgrade
|
| Total Common Shares Outstanding | 292.24 | 292.24 | 292.24 | 292.24 | 288.22 | 213.2 | Upgrade
|
| Working Capital | 4.35 | 3.52 | 8.2 | 18.55 | 26.17 | 5.64 | Upgrade
|
| Book Value Per Share | 0.01 | 0.02 | 0.03 | 0.08 | 0.14 | 0.06 | Upgrade
|
| Tangible Book Value | 4.32 | 5.5 | 9.07 | 24.12 | 40.78 | 12.87 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.02 | 0.03 | 0.08 | 0.14 | 0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.